All News

A panel of experts recently discussed the evolving field of immunotherapy for solid tumor types.

Immunotherapy continues to advance in melanoma and other solid tumor types as new combinations and biomarkers are being explored.

I really don't understand why some of us bear heavier burdens than others....

Two nonprofits teamed together to make a comprehensive online registry for patients and survivors of lung cancer.

A recent study looked at the relationship between obesity, MGUS and multiple myeloma.

Immunotherapy's role for treating sarcoma is being cemented as more agents and targets are identified.

We all deal with pain. For some of us, it is chronic, but we can't give up. Pain can be a tricky partner to walk along side and is different for everyone. For me, I must face it. I must try to heal it, and I must try to take steps forward, no matter how tiny they may be.

When it comes to employment and insurance after a cancer diagnosis, it is important to read the fine print.

Ibrance use will continue to grow for patients with ER-positive, HER2-negative metastatic breast cancer, Richard Finn, M.D., says.

After two transplants and two relapses, it's time to go down a novel road.

Here are some tips to make the holiday season go more smoothly.

TKIs will continue to shape the landscape of kidney cancer treatment, Robert A. Figlin, M.D., F.A.C.P., says.

On learning the difference between caregiver and seeing the signs of codependency.

Every patient with cancer deserves to be in a safe environment, so it is important to know the signs of an abusive caregiver.

Having multiple options for frontline treatment of CLL may be better than deciding on one standard, an expert says.

The combination of lirilumab Opdivo proved to be effective for a subet of patients with head and neck cancer, according to a recent study.

Journal writing can be your window to wellness.

Many breast cancer survivors use psychotropic and opioid medications, pointing to an unmet need for psychological care in this population.

Showing gratitude in spite of the changes that cancer brings.

A recent study outlined both the risks and benefits of sun exposure. Authors say that sensible sun exposure (without getting sun burn) may actually decrease a person's risk of getting melanoma.

The treatment landscape for chronic lymphocytic leukemia (CLL) is going to drastically change over the next decade or so, says Jose Leis, M.D.

Roman Perez-Soler, M.D. discusses the EGFR resistance in non-small cell lung cancer (NSCLC).

When a family member is diagnosed with breast cancer, all members of the family suffer in some way. The effects aren't always visible.

Learning to appreciate time after cancer.

In colorectal and other cancers, financial burden is worsened by expensive drugs, long-term treatment and sharing of insurance costs.

When it comes to bladder cancer, PD-1 and PD-L1 agents will become the new mainstay, says Jonathan E. Rosenberg, M.D.

Expert Howard I. Scher, M.D. discusses the future of liquid biopsy use for prostate cancer.